Back in February, the FDA proposed an update to the nutrition fact labels for food and drinks , which would be the first major update to these labels in over two decades...

Twitter summary: diasend system now compatible w/ more devices + fitness trackers - system available for patients free of charge! *UPDATE* On November 12, Diasend...

Robo-doctors? How new technologies might change the way you meet with your health care provider.

Twitter summary: dT presents at @US_FDA on interim results for CVOT trials in #diabetes & why we can’t delay innovation In 2008, the FDA mandated that companies...

The hope and hype of curing diabetes with stem cells – our take on the Harvard research and more.

In February, Johnson and Johnson announced that its SGLT-2 inhibitor for type 2 diabetes, Invokana (canagliflozin), will undergo trials as a treatment for diabetic...

Twitter Summary: Abbott receives EU Approval to launch Freestyle Libre – updates from EASD on payment, device accuracy, design, and user experience On September 3,...

Diabetes and distress: seven things to know and resources to help you take action

(S)he said what?!?

On May 20, the Diabetes Technology Society (DTS) announced the launch of a post-market blood glucose monitoring surveillance program , which will aim to assess and...

Twitter Summary: Free from fingersticks? Abbott names its Flash Glucose Monitor system the Freestyle Libre, set to launch in EU by end of 2014 On July 16, Abbott...

Twitter summary: Roche’s Lucentis granted “priority review” from FDA – decision by Feb. 2015, potentially 1 st ever eye medicine for diabetic retinopathy Roche recently...

Even diabetes experts find management challenging. How to go online and to your providers for support.

Twitter summary: BD’s new pen needle attacks #needlephobia at the source – now available at US pharmacies On August 6, BD announced the US launch of the Autoshield Duo...

What's the biggest impact you can make for people with diabetes this month? Tune in online for a patient meeting with the FDA!

On April 22, the FDA announced an exciting new program to accelerate access to medical devices that address major unmet needs. This should mean earlier and more...

Twitter summary: After huge anticipation for this innovative drug combination, Novo Nordisk’s Xultophy received approval in Europe for #T2D, 1 st ever basal insulin/GLP-...

(S)he said what?!?

At the 2014 American Diabetes Association conference, Maria Isabel Garcia, NP presented preliminary data from Project Dulce’s text-messaging based intervention, “Dulce...

Twitter summary: FDA approves Jardiance as third SGLT-2 inhibitor for #T2D, joins Invokana and Farxiga and potential future for #T1D On August 1, the FDA announced...